
IV Secukinumab for AxSpa
The FDA recently announced approval for intravenous secukinumab (Cosentyx) for adults with psoriatic arthritis, ankylosing spondylitis, and non-radiographic spondylitis.
https://t.co/JhOvPIXOMN https://t.co/GoV62NjSmf
Links:
IV Secukinumab for AxSpa | RheumNow
https://bit.ly/40K1AKi
20-11-2023